Verve Therapeutics Inc
NASDAQ:VERV
During the last 3 months Verve Therapeutics Inc insiders have not bought any shares, and sold 99.8k USD worth of shares. The stock price has dropped by 26% over this period (open performance analysis).
The last transaction was made on
Apr 2, 2025
by
Kathiresan Sekar
(Chief Financial Officer)
, who
sold
40.8k USD
worth of VERV shares.
During the last 3 months Verve Therapeutics Inc insiders have not bought any shares, and sold 99.8k USD worth of shares. The stock price has dropped by 26% over this period (open performance analysis).
The last transaction was made on
Apr 2, 2025
by
Kathiresan Sekar
(Chief Financial Officer)
, who
sold
40.8k USD
worth of VERV shares.
Verve Therapeutics Inc
Glance View
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. The company is headquartered in Cambridge, Massachusetts and currently employs 113 full-time employees. The company went IPO on 2021-06-17. The firm is engaged in pioneering a new approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The company is advancing a pipeline of single-course in vivo gene editing programs, each designed to mimic natural disease resistance mutations and turn off specific genes to lower blood lipids. The firm's initial two programs focuses on PCSK9 and ANGPTL3, two genes that regulate levels of blood lipids. Its pipeline of in vivo gene editing programs for atherosclerotic cardiovascular disease (ASCVD) includes VERVE-101 and ANGPTL3. The firm's lead product candidate, VERVE-101, is designed to be a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. Its second program is designed to permanently turn off the ANGPTL3 gene in the liver. ANGPTL3 is a key regulator of cholesterol and triglyceride metabolism.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet